Heron Neutron Medical and WHETRON Electronics, in which MiTAC Holdings Corporation holds an 11.27% indirect stake, submitted applications to the Taiwan Stock Exchange yesterday (May 28) to list their shares. These are the 10th and 11th domestic companies (excluding those on the Innovation Board) to apply for listing in 2025.

Heron Neutron Medical is led by Jin-Rong Hsu and has a paid-in capital of NT$1.407 billion. The company’s main products include medical equipment for boron neutron capture therapy (BNCT), BNCT-related diagnostic and therapeutic drugs, maintenance services for BNCT medical equipment, and radiation shielding planning services.

In 2024, Heron reported a pre-tax net loss of NT$260 million, with an after-tax loss per share of NT$2.04. For the first quarter of this year, the company reported an after-tax loss per share of NT$0.59.

WHETRON Electronics, headed by Yi-Hsing Chiang, has a paid-in capital of NT$780 million. Its main products include parking sensors, camera modules, and automotive anti-theft systems. In addition to MiTAC’s 11.27% indirect investment, Kenfin Investment and Shih Chan Investment hold 19.59% and 10.59% stakes in WHETRON, respectively.

WHETRON reported a pre-tax net profit of NT$246 million in 2024, with earnings per share (EPS) of NT$2.6. In the first quarter of this year, EPS stood at NT$0.48.

Resource: 禾榮科、輝創 送件申請上市